09/06/2026
At Asklepieia Health Cluster, we are committed to connecting patients with the world's most distinguished medical minds. We are proud to announce our collaboration with Dr. Marinos Tsiatas (BSc, MD, PhD, ESMO) — Medical Oncologist and Scientific Associate of Athens Medical Center, whose career bridges rigorous bench science and frontline clinical oncology.
By integrating Dr. Tsiatas' expertise into our ecosystem, we ensure that every patient has access to:
Immuno-Oncology at Its Frontier: A specialist in checkpoint inhibitor-based treatments (PD-1/PD-L1, CTLA-4) and combination immunotherapy regimens, trained at the Abramson Cancer Center, University of Pennsylvania — one of the world's leading cancer institutions.
Clinical Trial Leadership: As a Principal Investigator in dozens of Phase II–III international trials — including landmark studies in renal cell carcinoma, urothelial carcinoma, and breast cancer — Dr. Tsiatas brings access to tomorrow's therapies, today.
Deep Scientific Roots: With a PhD in Immunology and two decades of translational research, his clinical decisions are grounded in the science of how the immune system fights cancer — not just protocols.
Compassionate Precision Medicine: From bladder and prostate cancer to HER2-positive breast malignancies, Dr. Tsiatas offers individualized care that sees the patient, not just the diagnosis.
Together, we are more than a healthcare provider — we are a global bridge to world-class oncology, built on Greek medical excellence and an unwavering commitment to life. Because every patient deserves a fighter in their corner.
📍 Explore our elite network: www.asklepieiahealth.com
